Dr Michael Abouyannis

Biography

Michael Abouyannis is an Infectious Diseases Registrar based at the Royal Liverpool University Hospital and the Liverpool School of Tropical Medicine. He studied medicine at the University of Birmingham. His clinical experience includes junior and registrar training in Liverpool, emergency medicine and obstetrics in KwaZulu-Natal, and work as a clinician with Médecins Sans Frontières on the Uganda/Sudan border. His past academic experience includes HIV research at the Infectious Diseases Institute in Kampala, and TB and sepsis research in Malawi. Michael’s current research is focussed on early stage clinical trials to develop novel treatments for snakebite envenoming.

Research interests

Michael’s main research focuses are snakebite, early phase clinical trials, and drug repurposing.

Selected research publications

Handheld point-of-care devices for snakebite coagulopathy: a scoping review – Journal: Thrombosis and Haemostasis – Published: 1st May 2025

Development of an oral regimen of unithiol for the treatment of snakebite envenoming: a phase 1 open-label dose-escalation safety trial and pharmacokinetic analysis in healthy Kenyan adults. – Journal: eBioMedicine – Published: 27th February 2025

African polyvalent antivenom can maintain pharmacological stability and ability to neutralise murine venom lethality for decades post-expiry: evidence for increasing antivenom shelf life to aid in alleviating chronic shortages – Journal: BMJ Global Health – Published: 13th March 2024

Where do those data go? Reuse of screening results from clinical trials to estimate population prevalence of HBV infection in adults in Kilifi, Kenya – Journal: Journal of Virus Eradication – Published: 2nd December 2023

Définition d’un jeu universel de critères de décision de base pour les essais cliniques sur les morsures de serpent – Journal: Medecine tropicale et sante internationale (MTSI) – Published: 30th September 2023

View more publications